tldrdailynews.com logo

"Johnson & Johnson's Q1 Earnings Surge on Strong Medical Device Sales, Talc Issues Loom"

1 min read
Source: Benzinga
"Johnson & Johnson's Q1 Earnings Surge on Strong Medical Device Sales, Talc Issues Loom"
Photo: Benzinga
TL;DR

Johnson & Johnson reported first-quarter earnings that surpassed Wall Street estimates, with adjusted EPS of $2.71 and sales of $21.38 billion, driven by strong performance in its medical devices and innovative medicine segments. The company also raised its quarterly dividend and provided an upbeat outlook for fiscal year 2024.

Topics:businessbusiness-finance#business-finance#earnings#johnson-and-johnson#medical-devices#pharmaceuticals#sales
Share this article
  1. Johnson & Johnson Q1 Earnings Top Wall Street Estimates On Strong Medical Devices Sales, Drugmaker Boosts  Benzinga
  2. Johnson & Johnson tops quarterly profit estimates as medical device sales jump  CNBC
  3. Johnson & Johnson Stock Falls After Earnings Beat. Talc Issues Loom.  Barron's
  4. J&J's medical device sales fall short, cancer drugs seen growing  Reuters
  5. Read About Johnson & Johnson's 2024 First-Quarter Earnings  Johnson & Johnson

Want the full story? Read the original reporting

Read on Benzinga